During the European Cancer Congress, Vienna, Austria, Genentech announced positive results from two Phase II studies of atezolizumab in patients with advanced non-small ... Read more
Genentech recently announced results from a Phase II study, IMvigor 210, during the 2015 European Cancer Congress, Vienna, Austria. The trial assessed the use of investigational ... Read more
Researchers at the Peking Union Medical College and the Chinese Academy of Medical Sciences tested a new cellular therapy against prostate ... Read more
According to researchers at Image Guided Cancer Specialists, cryoablation can efficiently treat several types of cancer, destroying tumors from the inside ... Read more
In a recent study titled “Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer” and published in the Journal ... Read more
In a recent study, titled “Cancer Immunotherapy Employing an Innovative Strategy to Enhance CD4+ T Cell Help in the Tumor Microenvironment”, ... Read more
MicroConstants China Inc., has announced it gained the global rights from the Institute of Biophysics (IBP), Chinese Academy of Sciences (CAS) to develop ... Read more
